This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80388299
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunu de 1949 наукова стаття, опублікована в червні 1949 wetenschappelijk artikel 1949 թվականի հունիսի 1-ին հրատարակված գիտական հոդված scientific article published on 01 June 1949
p:P577
wds:Q80388299-A990E9BE-2A57-457E-8644-0108F6F1829E
wdt:P577
1949-06-01T00:00:00Z
p:P2093
wds:Q80388299-9C6FD1D8-B325-4C23-B0C4-A7FD349873FF wds:Q80388299-0C2C7064-DF15-4198-A865-BD00D93EEB85
wdt:P2093
HARVEY AM GROB D
rdfs:label
Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis
skos:prefLabel
Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis
schema:name
Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis
p:P1476
wds:Q80388299-17B1A0D2-54AC-4497-9B03-DE1F9B8A3438
wdt:P1476
Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis
p:P304
wds:Q80388299-1F04090D-A6B2-49CF-8338-CE357C3B4A8F
wdt:P304
532-567
p:P31
wds:Q80388299-2945661F-A75E-4F41-BC58-B6C0CB5F92B8
wdt:P31
wd:Q13442814
p:P921
wds:Q80388299-50233CE5-42E9-4EE4-AC7E-A9B723DCE0C0
wdt:P921
wd:Q8285
p:P698
wds:Q80388299-4CCF5BA7-C3FA-46FA-9C6D-3321FB905B2F
wdtn:P698
n7:18151257
wdt:P698
18151257
p:P1433
wds:Q80388299-E80BD56C-A9B5-4D89-BE82-AA8C097F0D50
wdt:P1433
wd:Q27718094
p:P433
wds:Q80388299-F216B8AA-2A89-461B-AD5F-E9C543BCAFDE
p:P478
wds:Q80388299-80246683-2892-4044-A8BA-CE243408F435
wdt:P433
6
wdt:P478
84